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A method for accurate measurement of GFR in conscious, spontane-
ously voiding rats. Renal function measurement by clearance methods
relies on accurately timed urine collection. In small experimental animals,
renal function measurement is usually performed under anesthesia and/or
with the application of bladder catheters to ensure accurate urine collec-
tion. To avoid both anesthesia and the need for bladder catheters we
developed a method to measure glomerular filtration rate (GFR) in
spontaneously voiding conscious rats. GFR was measured as the urinary
clearance of constantly infused '251-iothalamate. To correct for incom-
plete bladder emptying, urinary clearance of 251-iothalamate was multi-
plied by the ratio of plasma and urinary clearance of simultaneously
infused 311-hippuran, a correction method that has been previously
validated in humans. Reproducibility of the technique was evaluated by
analysis of the results of four consecutive clearance periods during the day
(intra-assay variation) in a group of 17 rats and of two consecutive
clearance periods on two or three separate days in a group of 20 rats
(inter-assay variation), all with normal renal function. Application of the
correction method reduced the intra-assay coefficient of variation
(mean so) from 37.4 14.3 to 5.4 2.3% (P < 0.05). The mean
inter-assay coefficient of variation fell slightly from 23.4 10.3 to 11.0
7.2% (P < 0.10). In rats with moderately impaired renal function (N = 8)
the intra-assay variation fell from 27.9 20.7 to 2.7 1.6% (P < 0.05).
Our data show that this correction method is a useful technique to assess
renal function in conscious, spontaneously voiding rats.
Renal function measurement in small experimental animals is
often performed by clearance methods. Since accurate measure-
ment of the glomerular filtration rate (GFR) by clearance meth-
ods relies on well timed urine collections, most studies are carried
out under anesthesia, or, if conscious, a few hours after instru-
mentation with bladder or ureter catheters. However, it is well-
recognized that both anesthesia and surgery affect GFR as well as
urinary excretion rates of sodium and water [1—3], even until
several hours after anesthesia and instrumentation [1, 4].
To avoid the effects of anesthesia, several techniques have been
developed to measure GFR in conscious rats [5—91. As rats do not
empty their bladder completely when voiding spontaneously [10],
chronically implanted bladder catheters are applied by several
investigators [5, 8] to ensure complete urine collection. Chronic
instrumentation of the bladder in rats, however, is cumbersome
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and can induce urological complications [11, 12]. In the present
study, therefore, we present a method for accurate measurement
of renal function as the clearance of constantly intravenously
infused '251-iothalamate in conscious, spontaneously voiding rats.
The problem of incomplete bladder emptying is circumvented by
a correction method for incomplete urine collection. This correc-
tion method has been extensively validated in humans [13, 141.
The aim of the present study was to test its feasibility in rats with
normal and moderately impaired renal function. In addition, we
tested whether the correction method could also be applied when
the tracer was administered by an intraperitoneal infusion route.
METHODS
Male Wistar rats 3 to 6 months of age, were studied (280 to
450 g). The animals were housed in individual cages in a temper-
ature controlled room with a 12 hour light/dark cycle. All animals
were fed with commercially available rat chow and tap water ad
libitum. During the renal function experiments food and water
were withheld to avoid the influence of food and water intake on
renal function.
One week before the experiments the rats (N = 17) were
instrumented. Anesthesia was induced with 4% isoflurane and
N,O:O2 (1:2). The right jugular vein was catheterized using
silicone tubing and the left carotid artery was catheterized with
polyethylene tubing fused to a silicone tubing. The proximal end
of each catheter was tunneled subcutaneously and exteriorized on
the head. The catheter was fixed on the skull by a (modified)
method previously described by Steffens [15]. The catheters were
filled with a 60% polyvinylpyrrolidone solution in saline with 500
lU/mi heparin closed with a piece of heat-sealed polyethylene
tubing.
In a second group of rats (N = 8) the right jugular vein was
catheterized as described above and a silicone catheter was
implanted in the peritoneal cavity through the abdominal wall.
Both catheters were tunneled subcutaneously and fixed on the
skull.
In a third group of rats (N = 8) moderate renal function
impairment was induced by adriamycin. To this purpose adriamy-
cm (1.5 mg/kg body wt; Pharmachemie B.V., Haarlem, Holland)
was injected intravenously. This model is characterized by pro-
teinuria and normal renal function at onset and, followed by
gradual impairment of renal function late in the disease [16].
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Table 1. Time course of duration between voidings (Tc collection),










mi/mm 100 g bodywt
1 60 25 2.34 0.88 2.48 0.84 1.04 0.33 0.99 0.20
2 46 11 1.86 0.60 2.44 0.77 0.82 0.27 1.00 0.22
3 60 15 2.44 0.74 2.47 0.65 0.91 0.21 1.02 0.23
4 48 11 1.89 0.52 2.42 0.73 0.91 0.26 1.05 0.22
mean 54 17 2.13 0.73 2.45 0.73 0.91 0.27 1.01 0.21
Renal function measurements were performed 8 weeks after
injection of adriamycin, that is after stabilization of proteinuria.
Clearance protocols
After seven days recovery from surgery the clearance experi-
ments were performed. The rats were unrestrained and awake in
a metabolic cage. To ensure a stable diuresis during the experi-
ments fifteen hours before the start of the experiment a continu-
ous infusion of a 5% dextrose solution (2 ml/hr) was started via
the jugular vein. At 8:00 a.m. a loading dose of 0.08 MBq
'251-iothalamate and 0.16 MBq 1311-hippuran in 300 gi dextrose
water was given, followed by a continuous infusion of 0.02 MBq
'251-iothalamate and 0.04 MBq 1311-hippuran per ml dextrose
water (2 ml/hr) via the carotid catheter by a constant infusion
pump (Harvard Instrument Company, South Natic, USA). After
an equilibration period of at least 120 minutes to establish steady
state hippuran and iothalamate plasma levels, collection of spon-
taneously voided urine portions started. Urine was collected by a
collection system which separates urine from feces. Following
every spontaneous micturition a blood sample of 300 j.d was
drawn via the jugular catheter. Rats were followed until four
clearance periods were completed. Blood was replaced with an
equal volume of dextrose water. In the second group of rats (N =
8) the bolus and the continuous infusion of the tracers were
administered by the intraperitoneal catheter.
Samples. Urine samples were collected in preweighed tubes and
volumes were measured gravimetrically. Blood samples were
collected in heparinized tubes. The blood samples were immedi-
ately centrifuged and a plasma sample of 150 pA was taken. The
activities of 1251-iothalamate and 1311-hippuran were determined
in 150 j.tl urine, in 150 pA plasma and in 20 pA standard infusion
solution using a two-channel scintillation counter (LKBG Corn-
pugamma scintillation counter; Wallace, Finland).
Renal function measurement
Standard GFR was calculated as the urinary clearance 1251
lothalamate, according to the formula:
Standard GFR = U101 * V
P101
where U,,, is counts/mm per ml urine, V is volume of urine in
mi/mm, and P01 is counts/mm per ml plasma. To correct the
standard GFR for inaccurate urine collection, the method as
described by Donker et al [13] and Apperloo et al [14] was
applied. This correction method relies on simultaneous infusion
of 1311-hippuran and 1251-iothalamate, andis based on the follow-
ing principles. Under conditions of steady state, that is, when
infusion rate equals excretion rate with consequently a stable
plasma level, the plasma clearance (I*V/P) and the renal clear-
ance (U*V/P) of '311-hippuran have been proven to be inter-
changeable in case of perfect urine collection (r = 0.998) in
humans [13]. Thus, simultaneous infusion of the radioisotopes
allows to correct the renal clearance of '251-iothalamate for
incorrect urine collection by using the following formula:
Corrected GFR = ('hip * VI/PhIP) * Standard GFR
(UhIP * VU/PhIP
where 'hip is counts/mm per ml of the infusion solution, V1 is
volume of the infusion in ml, Pj is counts/mm per ml plasma and
UhI is counts/mm per ml urine, V is volume of the urine in ml.
Simultaneous infusion of hippuran also gives the opportunity to
assess the ERPF, since hippuran is a marker of effective renal
plasma flow (ERPF).
Data analysis. The clearance of '251-iothalamate during a col-
lection period was calculated from the timed urine collection and
the bracketed plasma samples. The average of four clearance
periods was used to calculate mean GFR. The intra-assay coeffi-
cient of variation was measured using the four clearance periods
for the individual rats (N = 17). Interassay coefficient of variation
was measured by comparing measurements on two (N = 12) or
three (N = 8) separate days. A recovery period of at least seven
days was allowed between the study days. In the rats (N = 8) with
renal function impairment three clearance periods were used to
calculate mean GFR and intra-assay variation.
All data are expressed as mean SD. Statistical analysis was
performed by using the matched-pair Student's r-test. This was
used to compare the differences between the mean standard and
corrected GFR for each rat, respectively.
RESULTS
The presence of steady state is a prerequisite for the valid
application of this correction method for GFR. The presence of
steady state, that is, renal excretion of '311-hippuran equals
infusion rate, can be established by first, stable plasma levels, and
second, a complete urinary recovery of the infused '311-hippuran.
Plasma levels were stable; the average consecutive hippuran
counts were 383 58, 380 85, 383 109, 399 96 and 390
110 counts/mm, respectively. The urinary recovery of 1311-hippu-
ran in the experiments with the intra-arterial tracer infusion, was
90 11%. To test whether this incomplete recovery was due to
extrarenal loss of hippuran or incomplete urine collection, we
tested our urine collection system. Therefore 20 urine portions
ranging from 0.5 to 2 ml were used. We found an average loss of
10 8% urine, due to adhesion to the collection system.
To investigate whether the intra-arterial infusion route could he
replaced by an easier intraperitoneal route we tested the latter
technique in a second group of animals. The intraperitoneal
route, however, resulted only in a 68 8% recovery of hippuran,
thus precluding application of the correction method.
Collection time was by design determined by the interval
between spontaneous voiding. The voiding interval ranged from
20 to 120 minutes with an average period of 54 17 mm at the
infusion rate of 2 ml/hr. Urine volume ranged from 0.70 to 3.70 ml




















per voiding with an average of 2.13 0.73 ml. The time course of
mean values for duration between voidings, urine volume, urine
flow, standard and corrected GFR are given in Table 1. These
data show that during the experiment a certain variability between
the subsequent collection periods occurs for voiding interval,
urine volume, and standard GFR. After application of the cor-
rection method the variability in GFR between collection periods
tends to decrease somewhat.
Differences between the standard method and corrected
method become readily apparent when the individual coefficient
of variation of GFR between clearance periods are considered.
Figure 1 shows, first, the large intra-individual coefficient of
variation (CV) of the standard GFR and, second, a considerable
decrease of the individual CV after application of the correction
method. Moreover, Figure 1 shows that this reduction in CV of
GFR occurs in nearly all rats. This fall in CV was independent of
the prevailing GFR. The mean coefficient of variation of GFR fell
from 27.4 14.3% to 5.3 2.3% (P < 0.05), after application of
the correction method. To assess the inter-assay variation, renal
function was measured on two or three separate days in a group
of 20 rats. In comparison with the standard method, a lower
inter-assay coefficient of variation was obtained with the correc-
tion method as compared to the standard method (11.0 7.2%
vs. 23.4 10.3%).
To investigate whether the correction method was also appli-
cable in rats with impaired renal function we tested the technique
in 8 rats with established adriamycin nephrosis. The mean pro-
teinuria in this group was 603 148 mg!24 hr. In these rats, steady
state was also established within a time frame of two hours, as
indicated by stable plasma levels of '31[-hippuran. Average con-
secutive counts/mm were 565 70, 568 57, 609 75, 589
115, respectively. The second prerequisite for steady state the
urinary recovery of 1311-hippuran was also met, as shown by a
urinary recovery of 85 27%. The average of three clearance
periods resulted in mean standard GFR of 0.54 0.13 (mI/mm
100 g body wt) and a mean corrected GFR of 0.59 0.10 (ml/min
100 g body wt). A reduction in variability between the standard
and corrected GFR for each individual was also apparent in this
group; the intra-assay variation was lowered from 27.9 20.7 to
2.7 1.6% (P < 0.05) by application of the correction method.
DISCUSSION
The current study shows, first, that the results of GFR mea-
surement by renal clearance of continuously infused 25I
iothalamate are subject to a large intra-assay variation. Second,
we show that correcting GFR by the ratio of plasma and renal
clearance of coinfused hippuran considerably reduces the variabil-
ity. Lastly, we show that intraperitoneal infusion of the tracer
results in an incomplete recovery, and, consequently is not
applicable for renal function measurement according to this
design.
Several clearance techniques have been described to measure
renal function in conscious rats. Most methods require correctly
timed urine collection. As incomplete emptying of the bladder
upon spontaneous voiding can introduce substantial errors in the
assessment of urinary clearance of tracer substances, bladder
catheters are applied frequently. These, however, have disadvan-
tages such as the need for surgery, and sometimes the require-
ment of a restrainer [51. This induces additional stress and thus
can affect kidney function. Bladder catheters can also lead to
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Fig. 1. Coefficient of variation of standard (LI) and corrected (U) GFR for each rat.
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complications such as urinary tract infections and stone formation
[11, 12]. Furthermore, there is evidence that even with the use of
a bladder catheter urine collection may be incomplete as a
consequence of dead space [17]. To avoid the need of urine
collection, the single injection technique was recommended to
measure renal function in conscious rats [9]. Single injection
techniques assume that the marker is evenly distributed over the
extracellular volume and that equilibrium between the sampled
plasma and other body fluids is maintained as the kidney clears
the marker from the plasma. However, Schachter, Freinkel and
Schwartz [18] found that the concentration of inulin in the
extracellular fluid only is equal to that in plasma at one point in
time after injection. Alternative kinetic models have been advised
to overcome these problems of nonequilibrium among fluid
compartments. Most of these models still overestimate or under-
estimate true clearance [19, 20]. Moreover, single injection tech-
niques are not suited for acute pharmacological intervention
studies.
For these reasons, we prefer a technique based on the renal
clearance of continuously infused 1251-iothalamate. This tech-
nique has been used for years in humans, with application of a
correction method for incomplete urine collection [13, 14]. This
correction method allows to avoid bladder catheterization, but its
application is only justified during steady state conditions. In our
rat studies we obtained stable plasma tracer levels, and a urinary
recovery of 1311-hippuran of 90% and 85%. The major part of the
loss of 1311-hippuran, however, appeared to be accounted for by
adhesion to the collection system, rather than to extrarenal
clearance. Thus, application of the correction method appears to
be justified in renal function measurements in rats with normal
and moderately impaired renal function.
We did not test the method in rats with severe renal function
impairment. When renal function is severely impaired hippuran
clearance will be reduced accordingly. Under those circumstances,
equilibrium may not be reached within the time frame used here.
If so, the lack of equilibrium precludes application of our correc-
tion method. To adapt the method for use in rats with severe renal
function impairment either the time frame can be prolonged to
achieve equilibrium, or alternatively the bolus injection or the
infusion rate can be adapted. Such an adaptation, however, would
require separate validation.
The intraperitoneal infusion route was not acceptable since
only a 68% recovery was achieved. This poor recovery was
probably caused by incomplete intraperitoneal absorption of
hippuran or by substantial extrarenal clearance as a consequence
of increased excretion via the intestinal tract. In conclusion, we
were able to perform accurate renal function measurements in
spontaneously voiding conscious rats by using a method exten-
sively validated in humans. The lower variation of the corrected
GFR compared to the standard GFR, suggests that incomplete
bladder emptying, which is common in male rats, accounts for a
large part of the intra- and interassay variation in the GFR. The
obtained reduction in variability of GFR has two important
advantages. First, this method appears to be a suitable technique
to assess GFR during acute pharmacological intervention studies.
Second, the achieved reduction in variability of the GFR reduces
the number of animals needed to study effects of interventions on
renal function.
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